Library
أمينوركس
Is an anorectic stimulant drug that was taken of the market after it was found to cause pulmonary hypertension. Potency wise it has been found to be roughly 2.5 times more potent than dextroamphetamine.
Classification
- Chemical: Aminorex
- Psychoactive: Stimulant
- Tag: Habit-Forming
- Tag: Tentative
Effects
- Physical Energy
- Loss Of Appetite
- Insomnia
- Increased Heart Rate
- Increased Blood Pressure
- Teeth Grinding
- Euphoria
- Sociability Enhancement
- Anxiety
- Talkativeness
- Alertness Enhancement
- Empathy Enhancement
- Light Sensitivity
- Dehydration
- Increased Libido
- Vibrating Vision
- Open Eye Visuals
- Disinhibition
Routes of Administration
Oral
Dosage
- Common: 10-25 mg
- Light: 5-10 mg
- Strong: 10-25 mg
- Heavy: 40+ mg
- Threshold: 2-5 mg
Duration
- Onset: 0.33-1 h
- Peak: 2-4 h
- Offset: 4-10 h
- After Effects: 10-24 h
- Total Duration: 6-12 h
Insufflated
Dosage
- Heavy: 25+ mg
- Light: 3-8 mg
- Common: 8-15 mg
- Strong: 15-25 mg
- Threshold: 1-3 mg
Duration
- Onset: 0.08-0.25 h
- Peak: 1-3 h
- Offset: 3-8 h
- After Effects: 8-24 h
- Total Duration: 5-10 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.
